Tickers

1. Composite Trajectory Verdict

For an asset manager like FHI, the income statement (driven by AUM-linked revenue and operating leverage) and balance sheet (liquidity, leverage, equity capacity for buybacks/acquisitions) carry the most weight; cash flow is important but can diverge from earnings due to non-cash items and working capital timing.

Composite Trajectory: Improving

The annual income statement shows strong year-over-year improvement in 2025 versus 2024 across revenue (+10.3% to $1.801B), operating income (+42.2% to $513.9M), net income (+50.3% to $403.3M), and diluted EPS (+58.8% to $5.13) (10-K 2025-12-31, Consolidated Statements of Operations). The balance sheet strengthened with total equity rising 9.3% to $1.197B, cash increasing 15.5% to $582.5M, and leverage remaining low at 0.59x EBITDA with 48x interest coverage (10-K 2025-12-31, Consolidated Balance Sheets; 10-K 2025-12-31, MD&A Liquidity and Capital Resources). Operating cash flow declined 14.2% to $297.3M in 2025 despite higher net income, creating a divergence noted in the cash flow assessment, but free cash flow remained substantial and the trend over three years is roughly stable (10-K 2025-12-31, Consolidated Statements of Cash Flows). Quarterly financial statements for 2026 are not available in the provided filings, so the composite call rests on the annual trajectory.

2. Red Flags

• Earnings–cash flow divergence: Net income rose 50.3% YoY to $403.3M in 2025 while net cash from operations fell 14.2% to $297.3M, driven by a $117.5M increase in cash paid for trading securities, a $52.1M rise in distribution expense payments, and a $17.7M increase in incentive compensation payments (10-K 2025-12-31, Consolidated Statements of Operations; 10-K 2025-12-31, Consolidated Statements of Cash Flows).
• Intangible asset impairment sensitivity: The FHL indefinite-lived intangible asset ($97.3M carrying value) had a fair value exceeding carrying value by less than 5% as of Dec 31, 2025; a 10% decrease in projected revenue growth or pre-tax margins would reduce fair value by ~9% and ~16% respectively (10-K 2025-12-31, MD&A Critical Accounting Policies; 10-K 2025-12-31, Note 9).
• Rising fee waivers: Total fee waivers increased to $437.4M in 2025 from $428.0M in 2024, with money market waivers rising to $325.9M from $319.5M (10-K 2025-12-31, Note 6).
• Revenue concentration: ~27% of 2025 revenue came from two money market funds (Government Obligations 16%, Prime Cash Obligations 11%) and ~9% from a single intermediary (BNY Mellon/Pershing) (10-K 2025-12-31, Note 5).
• Legal contingency: Aberdeen City Council lawsuit seeks ~$118M (derivative) plus ~$45M (direct) related to a 2019 infrastructure investment; insurance receivable of $15.9M reclassified to long-term due to litigation delays (10-K 2025-12-31, Note 20).
• Special dividend distortion: 2024 dividends of $184.8M included an $84.2M special dividend ($1.00/share), making the 2025 dividend of $104.9M ($1.33/share) not directly comparable (10-K 2025-12-31, MD&A Dividends; 10-K 2025-12-31, Consolidated Statements of Cash Flows).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Overall Assessment: Revenue grew 10.3% to $1.801B in 2025 from $1.632B in 2024, driven by higher average money market (+9%) and equity (+11%) assets (10-K 2025-12-31, Consolidated Statements of Operations; 10-K 2025-12-31, MD&A Asset Highlights). Operating income surged 42.2% to $513.9M as total operating expenses rose only 1.3% to $1.287B; the expense increase was muted by a $65.6M decline in intangible asset expense (no impairment in 2025 vs. $66.3M in 2024) and a $16.1M decrease in other expense (VAT refund, FX) (10-K 2025-12-31, Consolidated Statements of Operations; 10-K 2025-12-31, MD&A Results of Operations). Net income jumped 50.3% to $403.3M, aided by a lower effective tax rate (24.4% vs. 29.7%) and higher nonoperating gains (10-K 2025-12-31, Consolidated Statements of Operations). Diluted EPS rose 58.8% to $5.13, boosted by share repurchases reducing the diluted share count to 75.1M from 79.4M (10-K 2025-12-31, Consolidated Statements of Operations; 10-K 2025-12-31, Note 16). The three-year annual trend (2023–2025) shows revenue +11.9%, operating income +32.6%, net income +34.9%, and EPS +50.9%.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Overall Assessment: Net cash from operating activities declined 14.2% to $297.3M in 2025 from $346.6M in 2024, despite a 54% increase in net income (including noncontrolling interests), primarily due to a $117.5M increase in cash paid for trading securities, higher distribution expense payments, and higher incentive compensation payments (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-K 2025-12-31, MD&A Liquidity and Capital Resources). Investing activities shifted to a modest $2.0M inflow in 2025 from a $64.3M inflow in 2024, reflecting $42.2M of redemptions offset by $18.7M of purchases, $12.8M for the Rivington acquisition, and $6.0M of fixed-asset deposits (10-K 2025-12-31, Consolidated Statements of Cash Flows). Financing outflows decreased to $237.9M from $286.4M, with share repurchases of $262.8M (up from $137.6M) and dividends of $104.9M (down from $184.8M due to the absence of a special dividend) partially offset by $163.9M of noncontrolling interest contributions (10-K 2025-12-31, Consolidated Statements of Cash Flows). Free cash flow (operating cash flow less capital expenditures of $2.8M) was $294.5M in 2025, below the $342.5M in 2024 but above the $303.9M in 2023 (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-K 2025-12-31, Note 10).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Overall Assessment: Total assets grew 6.9% to $2.229B at Dec 31, 2025 from $2.085B a year earlier, driven by higher cash ($582.5M vs. $504.4M), goodwill ($852.1M vs. $804.8M, including $35.6M from Rivington), and intangible assets ($331.5M vs. $327.9M) (10-K 2025-12-31, Consolidated Balance Sheets; 10-K 2025-12-31, Note 9). Total liabilities rose 3.4% to $965.9M, with long-term debt essentially flat at $348.4M (net of issuance costs) and deferred tax liabilities increasing to $183.5M from $171.0M (10-K 2025-12-31, Consolidated Balance Sheets; 10-K 2025-12-31, Note 11). Permanent equity increased 9.3% to $1.197B as retained earnings grew to $1.531B from $1.257B, while treasury stock expanded to $873.2M from $632.8M reflecting $263.4M of repurchases (10-K 2025-12-31, Consolidated Balance Sheets; 10-K 2025-12-31, Consolidated Statements of Changes in Equity). Leverage (debt/EBITDA) remained low at 0.59x against a 3.0x covenant, and interest coverage was 48x against a 4.0x minimum (10-K 2025-12-31, MD&A Liquidity and Capital Resources). The revolving credit facility was undrawn with $350M available plus a $200M accordion (10-K 2025-12-31, Note 11).

6. Data Gaps

• Quarterly income statements, cash flow statements, and balance sheets for Q2 2026, Q1 2026, Q3 2025, and Q2 2025 (the 10-Q filings for these periods are listed but their financial statement sections are not provided in the source material).
• Standalone Q4 2025 figures (cannot be derived by subtracting nine-month 10-Q data from the annual 10-K per instructions).
• Quarterly revenue, operating income, net income, EPS, operating cash flow, and free cash flow trends for 2025–2026.
• Detailed breakdown of the $117.5M increase in cash paid for trading securities in 2025 (referenced in MD&A but not separately line-itemed in the cash flow statement).
• Post-acquisition financial impact of the FCP acquisition (closed April 9, 2026) beyond the preliminary purchase price allocation disclosed in the 10-K.